Oramed Pharmaceuticals
ORMP
#9090
Rank
HK$0.94 B
Marketcap
HK$23.62
Share price
4.66%
Change (1 day)
21.03%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Cash on Hand

Cash on Hand as of June 2025 : HK$0.76 Billion

According to Oramed Pharmaceuticals's latest financial reports the company has HK$0.76 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$1.10 B-12.94%
2023-12-31HK$1.26 B4.02%
2022-12-31HK$1.21 B
2021-08-31HK$0.73 B136.79%
2020-08-31HK$0.30 B22.12%
2019-08-31HK$0.25 B5.9%
2018-08-31HK$0.23 B51.85%
2017-08-31HK$0.15 B-34.55%
2016-08-31HK$0.24 B80.17%
2015-08-31HK$0.13 B-19.07%
2014-08-31HK$0.16 B151.05%
2013-08-31HK$65.72 M66.62%
2012-08-31HK$39.44 M166.87%
2011-08-31HK$14.78 M58.37%
2010-08-31HK$9.33 M-55.68%
2009-08-31HK$21.05 M-45.99%
2008-08-31HK$38.98 M160.61%
2007-08-31HK$14.95 M991.88%
2006-08-31HK$1.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
HK$3.30 B 334.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$39.86 B 5,131.25%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$81.33 B 10,571.74%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
HK$0.66 B-12.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
HK$0.90 B 18.39%๐Ÿ‡บ๐Ÿ‡ธ USA